Abstract
Nineteen patients with severe oedema due to either cirrhosis of the liver or to congestive cardiac failure, who had failed to respond to previous diuretic therapy, were treated with either increasing doses of frusemide (Group A), or with frusemide in a fixed dose of 80 mg daily and increasing doses of spironolactone (Group B). In Group A there was an inverse correlation between the baseline 24-hr urinary sodium: potassium (Na : K) ratio and the 24-hr urinary potassium excretion during diuresis, and a direct correlation between the urinary Na : K ratio before and after diuresis. Thus, in patients of this group during diuresis, there was a significantly higher urinary potassium excretion in those with a baseline urinary Na : K ratio of less than 1, as compared with those with a ratio of greater than 1. In Group B a satisfactory diuresis was achieved without marked urinary potassium loss in those patients with a baseline urinary Na : K ratio of less than 1, whereas no diuresis was obtained in the two patients with a baseline urinary Na : K ratio of greater than 1. These results suggest that the measurement of the baseline urinary Na : K ratio is of help in determining the potential value of spironolactone in patients with resistant oedema.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adamson A. R., Jamieson S. W. Urinary excretion of sodium and potassium in relation to plasma aldosterone concentration. J Endocrinol. 1972 Jun;53(3):425–431. doi: 10.1677/joe.0.0530425. [DOI] [PubMed] [Google Scholar]
- BARTTER F. C. CARDIAC FAILURE AND HORMONAL CONTROL OF FLUID AND ELECTROLYTE BALANCE. Surg Gynecol Obstet. 1964 Apr;118:767–777. [PubMed] [Google Scholar]
- EDMONDS C. J. An aldosterone antagonist and diuretics in the treatment of chronic oedema and ascites. Lancet. 1960 Mar 5;1(7123):509–515. doi: 10.1016/s0140-6736(60)90448-7. [DOI] [PubMed] [Google Scholar]
- EDMONDS C. J., WILSON G. M. The action of hydroflumethiazide in relation to adrenal steroids and potassium loss. Lancet. 1960 Mar 5;1(7123):505–509. doi: 10.1016/s0140-6736(60)90447-5. [DOI] [PubMed] [Google Scholar]
- Eggert R. C. Spironolactone diuresis in patients with cirrhosis and ascites. Br Med J. 1970 Nov 14;4(5732):401–403. doi: 10.1136/bmj.4.5732.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MILLS J. N., THOMAS S., WILLIAMSON K. S. The effects of intravenous aldosterone and hydrocortisone on the urinary electrolytes of the recumbent human subject. J Physiol. 1961 May;156:415–423. doi: 10.1113/jphysiol.1961.sp006684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- READ A. E., LAIDLAW J., HASLAM R. M., SHERLOCK S. Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia. Clin Sci. 1959 Aug;18:409–423. [PubMed] [Google Scholar]
- SANDERS L. L., MELBY J. C. ALDOSTERONE AND THE EDEMA OF CONGESTIVE HEART FAILURE. Arch Intern Med. 1964 Mar;113:331–341. doi: 10.1001/archinte.1964.00280090017004. [DOI] [PubMed] [Google Scholar]
- Stason W. B., Cannon P. J., Heinemann H. O., Laragh J. H. Furosemide. A clinical evaluation of its diuretic action. Circulation. 1966 Nov;34(5):910–920. doi: 10.1161/01.cir.34.5.910. [DOI] [PubMed] [Google Scholar]
- THOMAS J. P., BARTTER F. C. Relation between diuretic agents and aldosterone in cardiac and cirrhotic patients with sodium retention. Br Med J. 1961 Apr 22;1(5233):1134–1139. doi: 10.1136/bmj.1.5233.1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VEREL D., STENTIFORD N. H., RAHMAN F., SAYNOR R. A CLINICAL TRIAL OF FRUSEMIDE. Lancet. 1964 Nov 21;2(7369):1088–1089. doi: 10.1016/s0140-6736(64)92609-1. [DOI] [PubMed] [Google Scholar]